Effect of introducing high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children
This is the main finding of a recent article based on data from The Streptococcus pneumoniae Invasive Disease network (SpIDnet).
WHO issues recommendation on the composition of influenza virus vaccines for the northern hemisphere 2015-2016
The World Health Organization (WHO) has agreed on the recommended composition of the trivalent influenza vaccine for the northern hemisphere 2015-2016 influenza season.
Assessing seasonal influenza vaccine effectiveness
On 3 December 2015, ECDC hosts a technical meeting to discuss influenza vaccine effectiveness studies and how they can best meet public health needs as well as regulatory requirements.
Lower than usual: early influenza vaccine effectiveness in parts of Europe in season 2011/12
A rapid communication published on April 12th 2012 describes the early results of the annual multicentre case-control study undertaken by the ECDC sponsored I-MOVE consortium whose work is coordinated by an Epiconcept team
The importance of analyses of antigenic match and monitoring influenza vaccine effectiveness
Influenza viruses pose a particular challenge for those designing vaccines for humans. Much of the protective immunity that humans have against these viruses following natural infection or vaccination is due to immunological recognition of the haemagglutinin (HA) surface glycoprotein.
Systematic review and meta-analysis concerning the efficacy and effectiveness of seasonal influenza vaccines – (part 1)
This is an authoritative independent evidence-based review and meta-analysis of the efficacy and effectiveness of influenza vaccines. It confines itself to trials and observational studies where diagnostic tests confirmed influenza infection as the end point.
Influenza vaccine effectiveness: results of the ECDC/I-MOVE studies and other studies
On the 26 October 2011, The Lancet Infectious Diseases published a systematic review and a meta-analysis, combining the results of several studies undertaken on influenza vaccine effectiveness.
Efficacy and safety of single and double doses of Ivermectin versus 7-day high dose Albendazole for chronic Strongyloidiasis
A prospective, randomized, open study was conducted in which a 7-day course of oral albendazole 800 mg daily was compared with a single dose (200 microgram/kilogram body weight) or double doses, given 2 weeks apart, of ivermectin in Thai patients with chronic strongyloidiasis.
Seasonal Influenza vaccine effectiveness in young children in Europe
This study was carried out in Finland and is one of the few European studies investigating the effectiveness of trivalent inactivated influenza vaccines against laboratory-confirmed influenza A and B infections in children younger than 3 years.